LifeMD LFMD
NASDAQ LFMD
$3.08 +0.03 (+0.98%)
At close: Sep 4, 2026 · 4:00 PM EDT

LifeMD (LFMD) Short term Debt (2017 - 2025)

LifeMD's (LFMD) quarterly Short term Debt came in at $12.0 million in Q2 2025, up 88.85% on a YoY basis from $6.3 million in Q2 2024, and up 3.01% quarter-over-quarter from $11.6 million in Q1 2025.

Analysis

LifeMD (LFMD) Short term Debt (2017 - 2025) Analysis & Trends

LifeMD (LFMD) has reported Short term Debt for 3 consecutive years, with $12.0 million the latest figure, recorded in Q2 2025.

  • For the quarter ending Q2 2025, Short term Debt rose 88.85% year-over-year to $12.0 million; the trailing twelve-month figure through Jun 2025 stood at $12.0 million (up 88.85% YoY), and the FY2024 full-year result was $8.4 million, changed N/A from the prior year.
  • Short term Debt improved to $12.0 million in Q2 2025 per LFMD's latest filing, from $11.6 million in the prior quarter.
  • Across five years, Short term Debt topped out at $12.0 million in Q2 2025 and bottomed at $4.0 million in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Hinge Health 7.41 Bn 7.03 Bn 183.95 Mn
2 Hims & Hers Health 6.47 Bn 5.63 Bn 480.80 Mn
3 Ethos Technologies 2.54 Bn 2.37 Bn 185.54 Mn
4 Omada Health 1.38 Bn 1.16 Bn 63.79 Mn
5 Teladoc Health 1.14 Bn 366.41 Mn 416.09 Mn
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn
7 Akso Health 259.44 Mn 259.25 Mn -
8 LifeMD 147.29 Mn 147.29 Mn -
9 eHealth 31.71 Mn -69.34 Mn -
10 Mangoceuticals 7.39 Mn 7.14 Mn 44,215.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 11.96 Mn
Mar 31, 2025 11.61 Mn
Dec 31, 2024 8.44 Mn
Sep 30, 2024 5.28 Mn
Jun 30, 2024 6.33 Mn
Mar 31, 2024 3.96 Mn
Dec 31, 2017 42,479.00